Literature DB >> 26820351

Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity.

Pooja Ghosh1, Atanu Singha Roy1, Susmitnarayan Chaudhury1, Saikat Kumar Jana2, Koel Chaudhury2, Swagata Dasgupta3.   

Abstract

Fisetin is a well known flavonoid that shows several properties such as antioxidant, antiviral and anticancer activities. Its use in the pharmaceutical field is limited due to its poor aqueous solubility which results in poor bioavailability and poor permeability. The aim of our present study is to prepare fisetin loaded human serum albumin nanoparticles to improve its bioavailability. The nanoparticles were prepared by a desolvation method and characterized by spectroscopic and microscopic techniques. The particles were smooth and spherical in nature with an average size of 220 ± 8 nm. The encapsulation efficiency was found to be 84%. The in vitro release profile showed a biphasic pattern and the release rate increases with increase in ionic strength of solution. We have also confirmed the antioxidant activity of the prepared nanoparticles by a DPPH (2,2-diphenyl-1-picrylhydrazyl) assay. Further its anticancer activity was evaluated using MCF-7 breast cancer cell lines. Our findings suggest that fisetin loaded HSA nanoparticles could be used to transfer fisetin to target areas under specific conditions and thus may find use as a delivery vehicle for the flavonoid.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxic; Hemolytic; Nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 26820351     DOI: 10.1016/j.ijbiomac.2016.01.082

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Osmoporation is a versatile technique to encapsulate fisetin using the probiotic bacteria Lactobacillus acidophilus.

Authors:  Eduardo Wagner Vasconcelos de Andrade; Sebastien Dupont; Laurent Beney; Roberta Targino Hoskin; Márcia Regina da Silva Pedrini
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-13       Impact factor: 4.813

Review 2.  Albumin nanostructures as advanced drug delivery systems.

Authors:  Mahdi Karimi; Sajad Bahrami; Soodeh Baghaee Ravari; Parham Sahandi Zangabad; Hamed Mirshekari; Mahnaz Bozorgomid; Somayeh Shahreza; Masume Sori; Michael R Hamblin
Journal:  Expert Opin Drug Deliv       Date:  2016-06-03       Impact factor: 6.648

Review 3.  Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy.

Authors:  Malgorzata Dobrzynska; Marta Napierala; Ewa Florek
Journal:  Biomolecules       Date:  2020-09-02

4.  Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa.

Authors:  Nazia Afroze; Sreepoorna Pramodh; Jasmin Shafarin; Khuloud Bajbouj; Mawieh Hamad; Madhumitha Kedhari Sundaram; Shafiul Haque; Arif Hussain
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

5.  Nanoencapsulation as a Promising Platform for the Delivery of the Morin-Cu(II) Complex: Antibacterial and Anticancer Potential.

Authors:  Pooja Ghosh; Sudipta Bag; Sultana Parveen; Elavarasan Subramani; Koel Chaudhury; Swagata Dasgupta
Journal:  ACS Omega       Date:  2022-02-22

6.  Nanoformulation Development to Improve the Biopharmaceutical Properties of Fisetin Using Design of Experiment Approach.

Authors:  Wan-Yi Liu; Chia-Chen Lin; Yun-Shan Hsieh; Yu-Tse Wu
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

7.  Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies.

Authors:  Xu Sun; Xueman Ma; Qiwei Li; Yong Yang; Xiaolong Xu; Jiaqi Sun; Mingwei Yu; Kexin Cao; Lin Yang; Guowang Yang; Ganlin Zhang; Xiaomin Wang
Journal:  Int J Mol Med       Date:  2018-05-02       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.